Characteristics | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
OR (95% CI) | P-value | OR (95% CI) | P-value | |
Age | 1.030 (0.994–1.068) | 0.105 |  |  |
Polymicrobial bacteremia | 1.917 (0.490–7.494) | 0.350 |  |  |
Neutropenia | 5.176 (1.252–21.411) | 0.023 | 4.988 (1.040–23.920) | 0.045 |
Hemoglobin < 60 g/L | 1.261 (0.433–3.668) | 0.671 |  |  |
Platelet< 50,000/uL | 1.500 (0.230–9.763) | 0.671 |  |  |
Fibrinogen< 2 g/L | 2.100 (0.537–8.217) | 0.286 |  |  |
PT > 13.5 s | 2.692 (0.883–8.206) | 0.082 |  |  |
APTT> 33.5 s | 2.265 (0.694–7.389) | 0.175 |  |  |
D-Dimer>700μg/L FEU | 1.568 (0.389–6.319) | 0.527 |  |  |
Albumin< 30 g/L | 1.440 (0.487–4.255) | 0.509 |  |  |
Globulin< 20 g/L | 1.261 (0.433–3.668) | 0.671 |  |  |
C-reactive protein≥10 mg/dl | 1.973 (0.638–6.106) | 0.238 |  |  |
Procalcitonin > 0.5μg/L | 9.375 (1.849–47.522) | 0.007 | 11.322 (1.943–65.956) | 0.007 |
HSCT | 1.167 (0.335–4.060) | 0.809 |  |  |
Inadequate initial antimicrobial treatment | 1.451 (0.481–4.377) | 0.508 |  |  |
Central venous catheter | 2.717 (0.479–15.402) | 0.259 |  |  |
Prior tigecycline therapy within 1 month | 4.364 (1.383–13.772) | 0.012 | 4.482 (1.135–17.702) | 0.032 |
Prior carbapenem therapy within 1 month | 1.250 (0.297–5.256) | 0.761 |  |  |